Manufacturer
KOTRA PHARMA (M) SDN. BHD.
Contents
Clobetasol propionate
Indication
Short-term treatment of corticosteroid-responsive resistant dermatoses eg, psoriasis, recalcitrant eczema, lichen planus, discoid lupus erythematosus & other conditions which do not respond satisfactorily to less active steroids.
Instruction
Apply once-bd.
Drug interaction
Increased systemic exposure w/ CYP3A4 enzyme inhibitors (e.g. itraconazole, ritonavir). May diminish the antineoplstic effect of aldesleukin. May potentiate the hyperglycaemic effect of ceritinib. May diminish the therapeutic effect of corticorelin and hyaluronidase. May enhance the adverse/toxic effects of deferasinox.
Malaysia
